Boenning & Scattergood’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.35M Buy
30,158
+15,550
+106% +$1.26M 0.54% 46
2022
Q3
$1.18M Sell
14,608
-2,118
-13% -$190K 0.24% 104
2022
Q2
$1.5M Sell
16,726
-13,432
-45% -$1.36M 0.28% 90
2022
Q1
$3.35M Sell
30,158
-399
-1% -$42.2K 0.54% 46
2021
Q4
$3.16M Buy
30,557
+134
+0.4% +$15.5K 0.51% 49
2021
Q3
$3.81M Buy
30,423
+348
+1% +$45K 0.67% 35
2021
Q2
$3.73M Buy
30,075
+5
+0% +$628 0.65% 36
2021
Q1
$3.55M Buy
30,070
+705
+2% +$82.6K 0.68% 37
2020
Q4
$3.44M Sell
29,365
-418
-1% -$46K 0.73% 31
2020
Q3
$3.1M Buy
29,783
+470
+2% +$47.2K 0.74% 29
2020
Q2
$2.69M Buy
29,313
+9,595
+49% +$920K 0.72% 33
2020
Q1
$1.78M Sell
19,718
-2,012
-9% -$214K 0.61% 41
2019
Q4
$2.46M Buy
21,730
+33
+0.2% +$3.62K 0.64% 40
2019
Q3
$2.36M Sell
21,697
-2,120
-9% -$221K 0.68% 38
2019
Q2
$2.32M Sell
23,817
-48
-0.2% -$4.38K 0.68% 36
2019
Q1
$2.17M Buy
23,865
+285
+1% +$25.5K 0.65% 38
2018
Q4
$2.15M Buy
23,580
+3,324
+16% +$311K 0.75% 29
2018
Q3
$1.99M Sell
20,256
-615
-3% -$56.9K 0.63% 40
2018
Q2
$1.79M Buy
+20,871
New +$1.74M 0.59% 45

Other funds holding MDT

Boenning & Scattergood's MDT Position: Q4 2022 in Review

Boenning & Scattergood increased its Medtronic (MDT) stake by 106% in Q4 2022, buying an estimated $1.26M and bringing the position to 30,158 shares worth $3.35M. The position accounts for 0.54% of the portfolio, ranked #46.

Boenning & Scattergood first reported a position in MDT in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.81M in Q3 2021. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Boenning & Scattergood held 30,158 shares of Medtronic worth $3.35M as of Q4 2022.
  • Boenning & Scattergood bought 15,550 Medtronic shares in Q4 2022, an estimated $1.26M.
  • Medtronic made up 0.54% of Boenning & Scattergood's portfolio in Q4 2022, its #46 holding.
  • Boenning & Scattergood first reported a position in Medtronic in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's Medtronic position peaked at $3.81M in Q3 2021.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.